SCOPUS 정보 검색 플랫폼

Volumn 48, Issue MAR., 2002, Pages 486-489

Analysis of serious adverse events. Lipid-lowering therapy revisited

(3) Wright, Jim M a Puil, Lorri a Bassett, Carol Lee Ken a

a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTILIPEMIC AGENT; ATORVASTATIN; BEZAFIBRATE; CERIVASTATIN; CLOFIBRATE; FIBRIC ACID DERIVATIVE; FLUINDOSTATIN; GEMFIBROZIL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; MEVINOLIN; PLACEBO; PRAVASTATIN; SIMVASTATIN;

ARTICLE; CARDIOVASCULAR DISEASE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CORONARY ARTERY ATHEROSCLEROSIS; DEATH; DRUG SAFETY; DRUG SURVEILLANCE PROGRAM; DRUG WITHDRAWAL; HEART INFARCTION; HOSPITALIZATION; HUMAN; MORTALITY; RANDOMIZED CONTROLLED TRIAL; RHABDOMYOLYSIS; RISK MANAGEMENT; SECONDARY PREVENTION; TREATMENT OUTCOME; UNITED STATES;

ANTILIPEMIC AGENTS; CARDIOVASCULAR DISEASES; CLOFIBRIC ACID; GEMFIBROZIL; HUMANS; HYDROXYMETHYLGLUTARYL COA REDUCTASES; MORTALITY; PATIENT SELECTION; RISK;

EID: 0036250235 PISSN: 0008350X EISSN: None Source Type: Journal
DOI: None Document Type: Article

Times cited : (3)

References (17)

1
- 0035941525
- Completeness of safety reporting in randomized trials: An evaluation of 7 medical areas
- (2001) JAMA , vol.285 , pp. 437-443
- Ioannidis, J.P.¹ Lau, J.²

2
- 0007862538
- Clinical safety data management: Definitions and standards for expedited reporting
- Expert working group (efficacy) of the International Conference on Harmonization of Technical Requirements for Registration of Pharmaceuticals for Human Use.
- (1995) Federal Register. , pp. 11284-11287

3
- 0003175887
- Lipid lowering therapy
- (1998) Ther. Lett. , vol.24 , pp. 1-2

4
- 2142794311
- Review Update 1998: Lipid lowering therapy
- (1998) Ther. Lett. , vol.27 , pp. 1-2

5
- 0032572086
- Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels
- Results of AFCAPS/TexCAPS. Air Force/Texas Coronary Atherosclerosis Prevention Study
- (1998) JAMA , vol.279 , pp. 1615-1622
- Downs, J.R.¹ Clearfield, M.² Weis, S.³ Whitney, E.⁴ Shapiro, D.R.⁵ Beere, P.A.⁶

6
- 0028883828
- Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia
- West of Scotland Coronary Prevention Study Group
- (1995) N. Engl. J. Med. , vol.333 , pp. 1301-1307
- Shepherd, J.¹ Cobbe, S.M.² Ford, I.³ Isles, C.G.⁴ Lorimer, A.R.⁵ MacFarlane, P.W.⁶

7
- 0027987849
- Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: The Scandinavian Simvastatin Survival Study (4S)
- Scandinavian Simvastatin Survival Study Group.
- (1994) Lancet , vol.344 , pp. 1383-1389

8
- 0342981862
- The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial investigators
- (1996) N. Engl. J. Med. , vol.335 , pp. 1001-1009
- Sacks, F.M.¹ Pfeffer, M.A.² Moye, L.A.³ Rouleau, J.L.⁴ Rutherford, J.D.⁵ Cole, T.G.⁶

9
- 0032487931
- Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels
- Long-Term Intervention with Pravastatin in Ischaemic Disease (LIPID) Study Group.
- (1998) N. Engl. J. Med. , vol.339 , pp. 1349-1357

10
- 0016630250
- Clofibrate and niacin in coronary heart disease
- Coronary Drug Project Research Group.
- (1975) JAMA , vol.231 , pp. 360-381

11
- 0033527030
- Gemfibrozil for the secondary prevention of coronary heart disease in men with low levels of high-density lipoprotein cholesterol
- Veterans Affairs High-Density Lipoprotein Cholesterol Intervention Trial Study Group.
- (1999) N. Engl. J. Med. , vol.341 , pp. 410-418
- Rubins, H.B.¹ Robins, S.J.² Collins, D.³ Fye, C.L.⁴ Anderson, J.W.⁵ Elam, M.B.⁶

12
- 0034604225
- Secondary prevention by raising HDL cholesterol and reducing triglycerides in patients with coronary artery disease. The Bezafibrate Infarction Prevention (BIP) study
- Bezafibrate Infarction Prevention study group.
- (2000) Circulation , vol.102 , pp. 21-27

13
- 0018117095
- A co-operative trial in the primary prevention of ischaemic heart disease using clofibrate
- Committee of Principal Investigators.
- (1978) Br. Heart J. , vol.40 , pp. 1069-1118

14
- 0023232216
- Helsinki Heart Study: Primary-prevention trial with gemfibrozil in middle-aged men with dyslipidemia. Safety of treatment, changes in risk factors, and incidence of coronary heart disease
- (1987) N. Engl. J. Med. , vol.317 , pp. 1237-1245
- Frick, M.H.¹ Elo, O.² Haapa, K.³ Heinonen, O.P.⁴ Heinsalmi, P.⁵ Helo, P.⁶

15
- 0034814994
- Sponsorship, authorship and accountability
- (2001) Can. Med. Assoc. J. , vol.165 , pp. 786-788
- Davidoff, F.¹ DeAngelis, C.D.² Drazen, J.M.³ Nicholls, M.G.⁴ Hoey, J.⁵ Hoigaard, L.⁶

16
- 0034814594
- Look, no strings: Publishing industry-funded research
- [editorial]
- (2001) Can. Med. Assoc. J. , vol.165 , pp. 733-735

17
- 0032619964
- Uniform requirements for manuscripts submitted to biomedical journals
- International Committee of Medical Journal Editors
- (1999) Med. Educ. , vol.33 , Issue.1 , pp. 66-78

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.